PME Breakfast Symposium (Non-CME)
Thursday, October 23 | 7:00 AM - 8:00 AM
A Triad of Diseases: A Treatment Strategy for Patients With T2D, CVD, and CKD
Davida F. Kruger, MSN, APN-BC,BC-ADM
Sponsored by Novo Nordisk.
Program Description:
PME Lunch Symposium (Non-CME)
Thursday, October 23 | 11:30 AM – 12:30 PM
Aldosterone as an underlying driver of hypertension and CV and kidney
Surendra Sivarajah, MD; Justin Fongemie, PharmD, BCCP
Sponsored by AstraZeneca.
Program Description:
Information is coming soon.
PME Dinner Symposium (Non-CME)
Thursday, October 23 | 6:15 PM - 7:15 PM
Tirzepatide: A Dual GIP and GLP-1 Receptor Agonist
Sponsored by Lilly.
Program Description:
Learn about tirzepatide, a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist, the active ingredient in Zepbound® (tirzepatide) and Mounjaro® (tirzepatide). In this program, we will review clinical efficacy, safety, and dosing and administration information about Zepbound and Mounjaro.
Attendees will have the opportunity to ask questions to the speaker at the conclusion of the program.
PME Breakfast Symposium (Non-CME)
Friday, October 24 | 6:45 AM – 7:45 AM
Sponsored by Corcept Therapeutics.
Program Description:
Information is coming soon.
PME Lunch Symposium (Non-CME)
Friday, October 24 | 12:30 PM – 1:30 PM
Sponsored by Novo Nordisk.
Program Description:
Information is coming soon.
PME Dinner Symposium (Non-CME)
Friday, October 24 | 6:30 PM - 7:30 PM
Evidence-Based Treatment of Recurrent Pericarditis
John Ryan, MD
Sponsored by Kiniksa Pharmaceuticals.
Program Description:
Information coming soon.
PME Breakfast Symposium (Non-CME)
Saturday, October 25 | 7:00 AM – 8:00 AM
Sponsored by Arrowhead Pharmaceuticals.
Program Description:
Information is coming soon.